Cirak Meltem Yalinay, Kalkanci Ayse, Kustimur Semra
Department of Medical Microbiology, Faculty of Medicine, Gazi University, Besevler, Ankara, Turkey.
Mem Inst Oswaldo Cruz. 2003 Dec;98(8):1027-32. doi: 10.1590/s0074-02762003000800009. Epub 2004 Mar 9.
The aim of this study was to evaluate the use of one of the molecular typing methods such as PCR (polymerase chain reaction) following by RFLP (restriction fragment length polymorphism) analysis in the identification of Candida species and then to differentiate the identified azole susceptible and resistant Candida albicans strains by using AP-PCR (arbitrarily primed-polymerase chain reaction). The identification of Candida species by PCR and RFLP analysis was based on the size and primary structural variation of rDNA intergenic spacer regions (ITS). Forty-four clinical Candida isolates comprising 5 species were included to the study. The amplification products were digested individually with 3 different restriction enzymes: HaeIII, DdeI, and BfaI. All the isolates tested yielded the expected band patterns by PCR and RFLP analysis. The results obtained from this study demonstrate that Candida species can be differentiated as C. albicans and non-C. albicans strains only by using HaeIII restriction enzyme and BfaI maintains the differentiation of these non-C. albicans species. After identification Candida species with RFLP analysis, C. albicans strains were included to the AP-PCR test. By using AP-PCR, fluconazole susceptible and resistant strains were differentiated. Nine fluconazole susceptible and 24 fluconazole resistant C. albicans were included to the study. Fluconazole resistant strains had more bands when evaluating with the agarose gel electrophoresis but there were no specific discriminatory band patterns to warrant the differentiation of the resistance. The identification of Candida species with the amplification of intergenic spacer region and RFLP analysis is a practical, short, and a reliable method when comparing to the conventional time-consuming Candida species identification methods. The fluconazole susceptibility testing with AP-PCR seems to be a promising method but further studies must be performed for more specific results.
本研究的目的是评估一种分子分型方法的应用,例如先采用聚合酶链反应(PCR),随后进行限制性片段长度多态性分析(RFLP),用于念珠菌属菌种的鉴定,然后通过任意引物聚合酶链反应(AP-PCR)区分已鉴定的对唑类敏感和耐药的白色念珠菌菌株。通过PCR和RFLP分析对念珠菌属菌种进行鉴定是基于核糖体DNA基因间隔区(ITS)的大小和一级结构变异。本研究纳入了包含5个菌种的44株临床念珠菌分离株。扩增产物分别用3种不同的限制性内切酶进行消化:HaeIII、DdeI和BfaI。通过PCR和RFLP分析,所有测试的分离株均产生了预期的条带模式。本研究获得的结果表明,仅使用HaeIII限制性内切酶就可以将念珠菌属菌种区分为白色念珠菌和非白色念珠菌菌株,而BfaI能维持这些非白色念珠菌菌种之间的区分。在用RFLP分析鉴定念珠菌属菌种后,将白色念珠菌菌株纳入AP-PCR检测。通过使用AP-PCR,区分了氟康唑敏感和耐药菌株。本研究纳入了9株氟康唑敏感和24株氟康唑耐药的白色念珠菌。在用琼脂糖凝胶电泳评估时,氟康唑耐药菌株有更多条带,但没有特定的鉴别条带模式来保证耐药性的区分。与传统的耗时的念珠菌属菌种鉴定方法相比,通过基因间隔区扩增和RFLP分析鉴定念珠菌属菌种是一种实用、快捷且可靠的方法。用AP-PCR进行氟康唑敏感性测试似乎是一种有前景的方法,但必须进行进一步研究以获得更具体的结果。